Gene Symbol | Gene ID | Gene Info |
---|---|---|
Dbp
|
ENSMUSG00000059824.4 | D site albumin promoter binding protein |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_45704714_45705075 | Dbp | 194 | 0.799822 | 0.47 | 2.8e-04 | Click! |
chr7_45704274_45704500 | Dbp | 701 | 0.306370 | 0.40 | 2.3e-03 | Click! |
chr7_45707222_45707925 | Dbp | 316 | 0.688611 | 0.36 | 7.2e-03 | Click! |
chr7_45706293_45707139 | Dbp | 388 | 0.610801 | 0.30 | 2.7e-02 | Click! |
chr7_45708190_45708721 | Dbp | 566 | 0.453038 | 0.25 | 7.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_95855291_95855553 | 7.15 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
9652 |
0.19 |
chr4_87806194_87806554 | 6.93 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
51 |
0.99 |
chr14_14351950_14353283 | 6.78 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr11_87368253_87368600 | 6.31 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
9403 |
0.12 |
chr15_79067699_79067850 | 5.57 |
Gm49471 |
predicted gene, 49471 |
3113 |
0.1 |
chr7_120867768_120868086 | 5.36 |
Gm15774 |
predicted gene 15774 |
7371 |
0.13 |
chr12_103737920_103738559 | 5.24 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr6_143068200_143068506 | 5.19 |
C2cd5 |
C2 calcium-dependent domain containing 5 |
1268 |
0.45 |
chr9_66626113_66626277 | 4.79 |
Usp3 |
ubiquitin specific peptidase 3 |
33053 |
0.16 |
chr9_116389002_116389158 | 4.76 |
D730003K21Rik |
RIKEN cDNA D730003K21 gene |
57912 |
0.15 |
chr10_21444559_21444841 | 4.74 |
Gm48386 |
predicted gene, 48386 |
936 |
0.49 |
chr12_103773603_103773784 | 4.66 |
Serpina1d |
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
101 |
0.94 |
chr11_4031163_4031533 | 4.55 |
Sec14l4 |
SEC14-like lipid binding 4 |
114 |
0.94 |
chr15_85469476_85469648 | 4.54 |
7530416G11Rik |
RIKEN cDNA 7530416G11 gene |
33665 |
0.15 |
chr10_96924338_96924633 | 4.44 |
Gm33981 |
predicted gene, 33981 |
34386 |
0.17 |
chr12_83073317_83073552 | 4.41 |
Gm29530 |
predicted gene 29530 |
25440 |
0.16 |
chr14_76817069_76817629 | 4.32 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr16_58498215_58498366 | 4.28 |
St3gal6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
1051 |
0.53 |
chr12_69367557_69367877 | 4.24 |
Gm18113 |
predicted gene, 18113 |
2306 |
0.15 |
chr10_127508848_127510720 | 4.20 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr10_96924676_96925079 | 4.11 |
Gm33981 |
predicted gene, 33981 |
33994 |
0.17 |
chr5_144372223_144372738 | 4.10 |
Dmrt1i |
Dmrt1 interacting ncRNA |
13955 |
0.16 |
chr9_61808528_61808859 | 4.07 |
Gm19208 |
predicted gene, 19208 |
43011 |
0.15 |
chr5_66081840_66082044 | 4.07 |
Rbm47 |
RNA binding motif protein 47 |
48 |
0.96 |
chr2_27981631_27981939 | 4.06 |
Col5a1 |
collagen, type V, alpha 1 |
35656 |
0.15 |
chr16_36062065_36062536 | 4.06 |
Fam162a |
family with sequence similarity 162, member A |
9069 |
0.11 |
chr1_21231877_21232055 | 4.06 |
Gm38224 |
predicted gene, 38224 |
2756 |
0.17 |
chr8_91381604_91381966 | 4.05 |
Fto |
fat mass and obesity associated |
8770 |
0.16 |
chr4_150685579_150685975 | 4.02 |
Gm16079 |
predicted gene 16079 |
6985 |
0.21 |
chr5_66080858_66081152 | 3.94 |
Rbm47 |
RNA binding motif protein 47 |
5 |
0.96 |
chr6_86832842_86833107 | 3.94 |
2610306M01Rik |
RIKEN cDNA 2610306M01 gene |
16466 |
0.12 |
chr15_77822081_77822487 | 3.94 |
Myh9 |
myosin, heavy polypeptide 9, non-muscle |
9053 |
0.15 |
chr1_185471753_185471924 | 3.89 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
15456 |
0.12 |
chr9_49365733_49366093 | 3.88 |
Drd2 |
dopamine receptor D2 |
25286 |
0.2 |
chr8_126178018_126178169 | 3.85 |
Slc35f3 |
solute carrier family 35, member F3 |
38711 |
0.19 |
chr11_54860143_54861186 | 3.79 |
Lyrm7 |
LYR motif containing 7 |
55 |
0.96 |
chr12_103956876_103957079 | 3.79 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
79 |
0.95 |
chr19_47431588_47431814 | 3.76 |
Sh3pxd2a |
SH3 and PX domains 2A |
21342 |
0.18 |
chr9_75236923_75237234 | 3.74 |
Myo5c |
myosin VC |
5002 |
0.19 |
chr6_125575147_125575338 | 3.72 |
Vwf |
Von Willebrand factor |
8991 |
0.21 |
chr12_103863072_103863984 | 3.71 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr18_79257106_79257504 | 3.70 |
Gm2116 |
predicted gene 2116 |
47857 |
0.15 |
chr8_106134810_106135562 | 3.69 |
Esrp2 |
epithelial splicing regulatory protein 2 |
90 |
0.67 |
chr13_62908154_62908567 | 3.69 |
Fbp1 |
fructose bisphosphatase 1 |
20078 |
0.13 |
chr11_121056618_121056859 | 3.67 |
Sectm1b |
secreted and transmembrane 1B |
110 |
0.92 |
chr1_191641396_191641769 | 3.67 |
Gm37349 |
predicted gene, 37349 |
43935 |
0.11 |
chr2_59353951_59354102 | 3.65 |
Pkp4 |
plakophilin 4 |
11829 |
0.19 |
chr10_98504531_98504809 | 3.62 |
Gm37631 |
predicted gene, 37631 |
17797 |
0.23 |
chr2_31459354_31459838 | 3.61 |
Hmcn2 |
hemicentin 2 |
4888 |
0.21 |
chr16_32453210_32453401 | 3.60 |
2210020O09Rik |
RIKEN cDNA 2210020O09 gene |
2844 |
0.17 |
chr11_60825346_60825507 | 3.58 |
Dhrs7b |
dehydrogenase/reductase (SDR family) member 7B |
5205 |
0.1 |
chr7_114322801_114323522 | 3.57 |
Psma1 |
proteasome subunit alpha 1 |
47043 |
0.14 |
chr9_64814339_64814687 | 3.55 |
Dennd4a |
DENN/MADD domain containing 4A |
2969 |
0.28 |
chr15_67146361_67146739 | 3.55 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
17527 |
0.24 |
chr12_103904902_103905107 | 3.50 |
Serpina1c |
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
117 |
0.93 |
chr8_126829447_126829889 | 3.49 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
9565 |
0.21 |
chr4_106248411_106248570 | 3.47 |
Gm12724 |
predicted gene 12724 |
7274 |
0.16 |
chr7_19685403_19685697 | 3.46 |
Apoc4 |
apolipoprotein C-IV |
4071 |
0.08 |
chr13_21831513_21832288 | 3.43 |
Hist1h4n |
histone cluster 1, H4n |
296 |
0.63 |
chr2_119566179_119566455 | 3.41 |
Chp1 |
calcineurin-like EF hand protein 1 |
288 |
0.85 |
chr6_124919273_124920636 | 3.39 |
Ptms |
parathymosin |
149 |
0.88 |
chr14_122511754_122511908 | 3.38 |
Gm18143 |
predicted gene, 18143 |
1998 |
0.22 |
chrX_150564268_150564425 | 3.36 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
2044 |
0.25 |
chr2_154632522_154632679 | 3.35 |
Gm14198 |
predicted gene 14198 |
36 |
0.96 |
chr13_93648920_93649103 | 3.35 |
Bhmt |
betaine-homocysteine methyltransferase |
11050 |
0.14 |
chr11_83224251_83224525 | 3.34 |
Gm11427 |
predicted gene 11427 |
66 |
0.72 |
chr4_140854328_140855106 | 3.32 |
Padi1 |
peptidyl arginine deiminase, type I |
8939 |
0.13 |
chr6_129113459_129113643 | 3.32 |
Klrb1-ps1 |
killer cell lectin-like receptor subfamily B member 1, pseudogene 1 |
2967 |
0.16 |
chr15_98606348_98606519 | 3.32 |
Adcy6 |
adenylate cyclase 6 |
1200 |
0.28 |
chr1_189756746_189757047 | 3.31 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
28621 |
0.16 |
chr7_110914639_110914941 | 3.29 |
Mrvi1 |
MRV integration site 1 |
8913 |
0.17 |
chr7_100466963_100467472 | 3.29 |
Gm10603 |
predicted gene 10603 |
27 |
0.95 |
chr14_31644308_31644459 | 3.29 |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
3097 |
0.17 |
chr17_50020574_50021045 | 3.25 |
AC133946.1 |
oxidoreductase NAD-binding domain containing 1 (OXNAD1) pseudogene |
47982 |
0.13 |
chr17_33951675_33951949 | 3.23 |
B3galt4 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
324 |
0.53 |
chr16_18428816_18428997 | 3.20 |
Txnrd2 |
thioredoxin reductase 2 |
19 |
0.95 |
chr11_106674335_106675138 | 3.18 |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
11410 |
0.17 |
chr11_87126714_87127907 | 3.18 |
Trim37 |
tripartite motif-containing 37 |
5 |
0.84 |
chr16_95929022_95929173 | 3.15 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
20 |
0.98 |
chr12_79799402_79799702 | 3.15 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
125181 |
0.05 |
chr4_141161724_141161914 | 3.15 |
Fbxo42 |
F-box protein 42 |
13897 |
0.11 |
chr4_119036970_119037397 | 3.14 |
Gm12866 |
predicted gene 12866 |
31928 |
0.08 |
chr12_52448287_52448487 | 3.14 |
Gm47431 |
predicted gene, 47431 |
262 |
0.93 |
chr14_60993588_60993857 | 3.12 |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
17837 |
0.22 |
chr10_119010890_119011286 | 3.09 |
Gm47461 |
predicted gene, 47461 |
10582 |
0.17 |
chr11_55168639_55168790 | 3.06 |
Slc36a2 |
solute carrier family 36 (proton/amino acid symporter), member 2 |
16363 |
0.11 |
chr11_24569735_24569998 | 3.05 |
Gm22787 |
predicted gene, 22787 |
15808 |
0.2 |
chr8_125910003_125910420 | 3.04 |
Map3k21 |
mitogen-activated protein kinase kinase kinase 21 |
239 |
0.92 |
chr8_106611054_106611250 | 3.01 |
Cdh1 |
cadherin 1 |
7009 |
0.18 |
chr7_103865767_103866083 | 2.99 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12709 |
0.06 |
chr7_127768560_127769629 | 2.99 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr7_126746842_126747128 | 2.99 |
Gm44855 |
predicted gene 44855 |
2570 |
0.09 |
chr6_121304708_121304879 | 2.98 |
Slc6a13 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 |
4011 |
0.17 |
chr15_102026499_102026806 | 2.98 |
Krt18 |
keratin 18 |
1528 |
0.27 |
chr11_109822407_109822575 | 2.98 |
1700012B07Rik |
RIKEN cDNA 1700012B07 gene |
5531 |
0.18 |
chr11_85529605_85529772 | 2.97 |
Bcas3 |
breast carcinoma amplified sequence 3 |
20050 |
0.21 |
chr11_84121422_84121573 | 2.97 |
Tada2a |
transcriptional adaptor 2A |
8103 |
0.17 |
chr11_85775247_85775913 | 2.97 |
Bcas3os2 |
breast carcinoma amplified sequence 3 opposite strand 2 |
100 |
0.95 |
chr1_37041206_37041380 | 2.95 |
Vwa3b |
von Willebrand factor A domain containing 3B |
5585 |
0.2 |
chr1_166014624_166014882 | 2.95 |
Gm26665 |
predicted gene, 26665 |
11793 |
0.15 |
chr1_184478143_184478295 | 2.95 |
2900092O11Rik |
RIKEN cDNA 2900092O11 gene |
35239 |
0.16 |
chr9_70926847_70927150 | 2.94 |
Gm32017 |
predicted gene, 32017 |
3490 |
0.25 |
chr8_109584965_109585123 | 2.94 |
Hp |
haptoglobin |
5872 |
0.14 |
chr3_86799093_86799409 | 2.93 |
Dclk2 |
doublecortin-like kinase 2 |
91 |
0.97 |
chr6_95936629_95936799 | 2.91 |
Gm7838 |
predicted gene 7838 |
9785 |
0.29 |
chr17_88614360_88614660 | 2.90 |
Gm9406 |
predicted gene 9406 |
5966 |
0.17 |
chr6_5297261_5297549 | 2.90 |
Pon2 |
paraoxonase 2 |
925 |
0.57 |
chr14_30829174_30829399 | 2.89 |
Stimate |
STIM activating enhancer |
3692 |
0.16 |
chr11_87750589_87750762 | 2.89 |
Mir142hg |
Mir142 host gene (non-protein coding) |
4902 |
0.1 |
chr9_79004588_79004980 | 2.89 |
Gm35024 |
predicted gene, 35024 |
24968 |
0.19 |
chr18_36661329_36661480 | 2.88 |
Eif4ebp3 |
eukaryotic translation initiation factor 4E binding protein 3 |
2656 |
0.12 |
chr1_134491206_134491391 | 2.88 |
Rabif |
RAB interacting factor |
3350 |
0.13 |
chr4_151957701_151957865 | 2.88 |
Dnajc11 |
DnaJ heat shock protein family (Hsp40) member C11 |
640 |
0.62 |
chr15_79658389_79659050 | 2.88 |
Fam227a |
family with sequence similarity 227, member A |
30 |
0.87 |
chr14_59533074_59533246 | 2.88 |
Cab39l |
calcium binding protein 39-like |
54344 |
0.1 |
chr11_29660854_29661063 | 2.87 |
Gm12092 |
predicted gene 12092 |
15449 |
0.14 |
chr3_116614535_116614842 | 2.87 |
Trmt13 |
tRNA methyltransferase 13 |
101 |
0.92 |
chr17_64782444_64782606 | 2.87 |
Dreh |
down-regulated in hepatocellular carcinoma |
15414 |
0.19 |
chr3_96220445_96221400 | 2.85 |
H2ac20 |
H2A clustered histone 20 |
42 |
0.58 |
chr3_83039790_83039970 | 2.84 |
Fgb |
fibrinogen beta chain |
9983 |
0.14 |
chr15_100685293_100685485 | 2.84 |
Cela1 |
chymotrypsin-like elastase family, member 1 |
25 |
0.95 |
chr1_175607974_175608194 | 2.83 |
Fh1 |
fumarate hydratase 1 |
1437 |
0.39 |
chr5_146687980_146688258 | 2.81 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
18503 |
0.16 |
chr5_90431211_90431385 | 2.80 |
Alb |
albumin |
29599 |
0.13 |
chr17_25961534_25961819 | 2.80 |
Capn15 |
calpain 15 |
2084 |
0.13 |
chr9_50811130_50811331 | 2.80 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
2551 |
0.2 |
chr13_99100048_99100764 | 2.80 |
Gm807 |
predicted gene 807 |
300 |
0.89 |
chr5_74064910_74065186 | 2.80 |
Usp46 |
ubiquitin specific peptidase 46 |
700 |
0.53 |
chr6_131387171_131387443 | 2.79 |
Ybx3 |
Y box protein 3 |
1131 |
0.41 |
chr19_55091888_55092144 | 2.79 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
7435 |
0.21 |
chr19_17323425_17323682 | 2.78 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
11883 |
0.21 |
chr9_98422770_98422981 | 2.78 |
Rbp1 |
retinol binding protein 1, cellular |
86 |
0.98 |
chr5_130074634_130074796 | 2.78 |
Tpst1 |
protein-tyrosine sulfotransferase 1 |
1389 |
0.33 |
chr13_59796221_59796392 | 2.77 |
Tut7 |
terminal uridylyl transferase 7 |
824 |
0.42 |
chr4_32570992_32571180 | 2.76 |
Bach2os |
BTB and CNC homology 2, opposite strand |
531 |
0.72 |
chr14_59880775_59881099 | 2.76 |
Gm9013 |
predicted gene 9013 |
159554 |
0.03 |
chr14_76733384_76733551 | 2.76 |
4930431P22Rik |
RIKEN cDNA 4930431P22 gene |
26664 |
0.17 |
chr15_78318816_78319112 | 2.75 |
Csf2rb |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
6788 |
0.12 |
chr12_80778673_80778853 | 2.75 |
Gm47941 |
predicted gene, 47941 |
11580 |
0.12 |
chr6_116350044_116350568 | 2.74 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
79 |
0.95 |
chr4_132590756_132590907 | 2.74 |
Ptafr |
platelet-activating factor receptor |
26764 |
0.1 |
chr1_184536649_184536800 | 2.74 |
1700112H15Rik |
RIKEN cDNA 1700112H15 gene |
20967 |
0.17 |
chr7_110164070_110164664 | 2.74 |
1600010M07Rik |
RIKEN cDNA 1600010M07 gene |
13165 |
0.15 |
chr11_115912151_115912342 | 2.71 |
Smim6 |
small integral membrane protein 6 |
229 |
0.85 |
chr18_21152139_21152308 | 2.71 |
Gm6378 |
predicted pseudogene 6378 |
75114 |
0.09 |
chr4_144957270_144957482 | 2.71 |
Gm38074 |
predicted gene, 38074 |
1472 |
0.42 |
chr6_30147836_30147994 | 2.71 |
Mir182 |
microRNA 182 |
18077 |
0.12 |
chr9_45201259_45201516 | 2.71 |
Tmprss4 |
transmembrane protease, serine 4 |
2599 |
0.15 |
chr8_94354649_94354841 | 2.70 |
Slc12a3 |
solute carrier family 12, member 3 |
301 |
0.82 |
chr8_44705001_44705152 | 2.69 |
Gm26089 |
predicted gene, 26089 |
103243 |
0.07 |
chr9_114842135_114842610 | 2.69 |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
1729 |
0.32 |
chr10_61534398_61535221 | 2.69 |
Gm17829 |
predicted gene, 17829 |
24224 |
0.1 |
chr7_142574309_142575453 | 2.68 |
H19 |
H19, imprinted maternally expressed transcript |
1657 |
0.21 |
chr3_131729065_131729216 | 2.68 |
Gm29865 |
predicted gene, 29865 |
30665 |
0.22 |
chr19_53965032_53965401 | 2.68 |
Gm50273 |
predicted gene, 50273 |
2447 |
0.22 |
chr10_4239811_4240108 | 2.68 |
Akap12 |
A kinase (PRKA) anchor protein (gravin) 12 |
26421 |
0.16 |
chr5_57782194_57782347 | 2.67 |
Gm42481 |
predicted gene 42481 |
3397 |
0.17 |
chr7_75613456_75613616 | 2.67 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
1152 |
0.52 |
chr10_53930227_53930492 | 2.67 |
Man1a |
mannosidase 1, alpha |
46756 |
0.16 |
chr8_46540102_46540334 | 2.66 |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
9154 |
0.15 |
chr4_62384264_62384428 | 2.66 |
Slc31a1 |
solute carrier family 31, member 1 |
1155 |
0.38 |
chr11_116506385_116506879 | 2.66 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr5_116447949_116448235 | 2.66 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1248 |
0.35 |
chr5_148965768_148966295 | 2.65 |
1810059H22Rik |
RIKEN cDNA 1810059H22 gene |
1757 |
0.18 |
chr4_141131586_141132124 | 2.64 |
Szrd1 |
SUZ RNA binding domain containing 1 |
7872 |
0.11 |
chr2_134976806_134976969 | 2.64 |
Gm14036 |
predicted gene 14036 |
172938 |
0.03 |
chr9_53422571_53422732 | 2.64 |
4930550C14Rik |
RIKEN cDNA 4930550C14 gene |
17353 |
0.14 |
chr15_27910245_27910441 | 2.64 |
Trio |
triple functional domain (PTPRF interacting) |
8928 |
0.22 |
chr8_34622313_34622510 | 2.63 |
Gm34096 |
predicted gene, 34096 |
14106 |
0.17 |
chr11_61197103_61197254 | 2.63 |
Rps13-ps5 |
ribosomal protein S13, pseudogene 5 |
8997 |
0.14 |
chr13_37715025_37715360 | 2.62 |
Gm40918 |
predicted gene, 40918 |
1119 |
0.39 |
chr19_55938421_55938984 | 2.62 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40393 |
0.17 |
chr1_182256144_182256327 | 2.62 |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
25989 |
0.15 |
chr9_98298839_98299188 | 2.62 |
Nmnat3 |
nicotinamide nucleotide adenylyltransferase 3 |
2351 |
0.29 |
chr5_100638641_100638903 | 2.61 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
25647 |
0.12 |
chr1_191178777_191178928 | 2.60 |
Atf3 |
activating transcription factor 3 |
4256 |
0.16 |
chr6_86599873_86600458 | 2.59 |
Gm44369 |
predicted gene, 44369 |
8735 |
0.11 |
chr9_110699835_110699986 | 2.59 |
Ccdc12 |
coiled-coil domain containing 12 |
9984 |
0.11 |
chr8_88118496_88118819 | 2.59 |
Cnep1r1 |
CTD nuclear envelope phosphatase 1 regulatory subunit 1 |
112 |
0.95 |
chr19_55257565_55258057 | 2.59 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
4442 |
0.2 |
chr7_90045311_90045488 | 2.59 |
Gm44861 |
predicted gene 44861 |
2702 |
0.19 |
chr17_12385565_12385750 | 2.58 |
Plg |
plasminogen |
6998 |
0.17 |
chr13_112046615_112046776 | 2.58 |
Gm15323 |
predicted gene 15323 |
41193 |
0.14 |
chr12_84400800_84400985 | 2.57 |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
7 |
0.96 |
chr11_107012211_107012554 | 2.57 |
Gm11708 |
predicted gene 11708 |
7642 |
0.13 |
chr19_43999221_43999522 | 2.57 |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
12815 |
0.14 |
chr17_12378400_12378705 | 2.56 |
Plg |
plasminogen |
56 |
0.97 |
chr7_119620199_119620358 | 2.56 |
Gm19950 |
predicted gene, 19950 |
19 |
0.96 |
chr9_50813897_50814068 | 2.55 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
5303 |
0.15 |
chr7_141340446_141340765 | 2.55 |
Eps8l2 |
EPS8-like 2 |
1599 |
0.18 |
chr14_55540009_55540830 | 2.55 |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
6 |
0.92 |
chr11_115292903_115293236 | 2.55 |
Fads6 |
fatty acid desaturase domain family, member 6 |
4445 |
0.11 |
chr8_18731044_18731219 | 2.55 |
Angpt2 |
angiopoietin 2 |
10431 |
0.19 |
chr4_82815311_82815597 | 2.55 |
Zdhhc21 |
zinc finger, DHHC domain containing 21 |
35360 |
0.17 |
chr5_34910311_34910479 | 2.54 |
Msantd1 |
Myb/SANT-like DNA-binding domain containing 1 |
2383 |
0.27 |
chr4_129256465_129256870 | 2.53 |
C77080 |
expressed sequence C77080 |
4737 |
0.13 |
chr19_38015569_38015929 | 2.53 |
Myof |
myoferlin |
27602 |
0.14 |
chr7_16310401_16311417 | 2.53 |
Bbc3 |
BCL2 binding component 3 |
454 |
0.72 |
chr5_146289523_146289857 | 2.53 |
Cdk8 |
cyclin-dependent kinase 8 |
3514 |
0.21 |
chr1_184276151_184276302 | 2.52 |
Gm37223 |
predicted gene, 37223 |
82103 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.7 | 5.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.4 | 4.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.4 | 5.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.3 | 4.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.3 | 3.8 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.2 | 3.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.1 | 4.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.1 | 3.4 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.1 | 3.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.1 | 4.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.1 | 3.2 | GO:0000087 | mitotic M phase(GO:0000087) |
1.1 | 3.2 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.0 | 3.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.0 | 1.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.0 | 3.8 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.0 | 2.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.9 | 2.8 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.9 | 3.7 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.9 | 5.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.9 | 1.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.9 | 2.7 | GO:0050904 | diapedesis(GO:0050904) |
0.9 | 7.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.9 | 2.6 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.9 | 3.5 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.9 | 3.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.9 | 0.9 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.9 | 2.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.8 | 4.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.8 | 2.5 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.8 | 2.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.8 | 2.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.8 | 4.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.8 | 4.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.8 | 0.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.8 | 2.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.8 | 1.6 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 2.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.8 | 4.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.8 | 2.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.8 | 4.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.8 | 3.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.8 | 3.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.8 | 2.3 | GO:0032439 | endosome localization(GO:0032439) |
0.8 | 5.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.8 | 2.3 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.8 | 2.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.8 | 2.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.7 | 3.0 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.7 | 2.2 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.7 | 5.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 2.9 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.7 | 1.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 2.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.7 | 2.1 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 0.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.7 | 2.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 4.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 2.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.7 | 2.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.7 | 3.5 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.7 | 2.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 3.5 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.7 | 2.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.7 | 2.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.7 | 0.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.7 | 2.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.7 | 4.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.7 | 2.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.7 | 2.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.7 | 2.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.7 | 2.0 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 2.6 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.7 | 2.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.6 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 2.6 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.6 | 1.9 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.6 | 4.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 1.3 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.6 | 1.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.6 | 1.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.6 | 4.4 | GO:0015677 | copper ion import(GO:0015677) |
0.6 | 2.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.6 | 3.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.6 | 2.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 4.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.6 | 1.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 3.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 2.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.6 | 4.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.6 | 1.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 3.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 1.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 6.9 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.6 | 10.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.6 | 1.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 2.3 | GO:0060066 | oviduct development(GO:0060066) |
0.6 | 2.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 1.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 0.6 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.6 | 0.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.6 | 4.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.6 | 3.4 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.6 | 1.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 2.8 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.6 | 1.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.6 | 1.7 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.6 | 1.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.6 | 2.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.6 | 2.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.6 | 1.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.5 | 2.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 0.5 | GO:0009838 | abscission(GO:0009838) |
0.5 | 3.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.5 | 1.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 1.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.5 | 1.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 1.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 2.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 3.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 0.5 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.5 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 2.1 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.5 | 2.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 2.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.5 | 1.6 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 1.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 1.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 2.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 1.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.5 | 1.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 2.0 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.5 | 0.5 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.5 | 1.0 | GO:0010878 | cholesterol storage(GO:0010878) |
0.5 | 2.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 1.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.5 | 2.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 2.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 1.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.5 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 1.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.5 | 1.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 3.0 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 1.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.5 | 1.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 1.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.5 | 2.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.5 | 1.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.5 | 1.4 | GO:0015817 | histidine transport(GO:0015817) |
0.5 | 1.0 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.5 | 1.0 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 1.9 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.5 | 3.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 2.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 1.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 8.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 6.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.5 | 2.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.5 | 1.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 0.9 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.5 | 1.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 1.8 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 1.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.5 | 1.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 0.9 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.5 | 0.9 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.5 | 1.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 0.4 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.4 | 3.1 | GO:0000050 | urea cycle(GO:0000050) |
0.4 | 1.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 1.3 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.4 | 1.3 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.4 | 3.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.4 | 2.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.4 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.4 | 1.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 2.2 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.4 | 1.3 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 0.4 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.4 | 3.5 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.4 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 0.4 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.4 | 0.4 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.4 | 1.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 1.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 0.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 3.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 1.7 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.4 | 1.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 1.7 | GO:0035459 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) COPII-coated vesicle budding(GO:0090114) |
0.4 | 0.4 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.4 | 3.4 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.4 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 1.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 1.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 2.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 2.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.4 | 2.9 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 2.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 0.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.4 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.2 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 3.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 2.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 4.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 1.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.4 | 1.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 0.4 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.4 | 1.6 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.4 | 1.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.4 | 1.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 0.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 13.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.4 | 1.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.4 | 5.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 2.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 1.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.4 | 1.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.4 | 5.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.4 | 0.4 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.4 | 0.8 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.4 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 1.6 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 0.4 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.4 | 0.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 0.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 0.8 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.4 | 1.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.4 | 0.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.4 | 1.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 1.5 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.4 | 1.1 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 2.3 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.4 | 2.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 1.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 7.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.4 | 1.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 0.4 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.4 | 1.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 2.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 1.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 1.5 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.4 | 3.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 0.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.4 | 2.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 1.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.4 | 1.4 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 2.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 0.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.4 | 0.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.4 | 1.4 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.4 | 0.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.4 | 1.4 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.4 | 0.7 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.4 | 2.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.8 | GO:0034204 | lipid translocation(GO:0034204) |
0.4 | 3.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 1.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 1.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 1.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 0.7 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 2.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 1.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 2.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.7 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.3 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 0.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 1.0 | GO:0097286 | iron ion import(GO:0097286) |
0.3 | 0.7 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 1.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 2.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 3.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 0.7 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 0.3 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.3 | 1.0 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 0.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 0.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.3 | 0.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 1.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 5.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 0.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.3 | 0.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 1.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 1.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 1.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.3 | 3.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 0.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 1.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 0.7 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 1.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 1.0 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 1.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.3 | 0.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.3 | 1.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 1.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 2.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 0.7 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.3 | 1.6 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 1.3 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.3 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.6 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.3 | 2.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 1.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 5.8 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.3 | 0.6 | GO:0042701 | progesterone secretion(GO:0042701) |
0.3 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 0.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 9.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 1.3 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 0.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 3.2 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.3 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.6 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.3 | 0.9 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.3 | 1.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 1.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 1.9 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 1.2 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.3 | 2.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 2.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 1.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 0.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 0.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 1.5 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.3 | 0.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.3 | 2.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.9 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 0.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.3 | 1.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.3 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.3 | 0.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 1.5 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 3.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 2.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 3.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 2.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.9 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 3.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 1.8 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 2.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 1.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.3 | 1.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 1.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 0.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 2.3 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 3.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 0.9 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 1.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 0.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 1.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 1.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 2.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.3 | 0.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.3 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.3 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.3 | 2.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 0.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 1.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.3 | 0.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 2.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 1.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 0.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 1.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.3 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 0.6 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.3 | 4.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 2.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 0.8 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 1.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 0.6 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.3 | 1.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.3 | 1.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.3 | 1.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 1.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.3 | 3.8 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.3 | 0.5 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.3 | 0.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.6 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 0.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 1.4 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.8 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.3 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.3 | GO:1990748 | cellular detoxification(GO:1990748) |
0.3 | 0.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 0.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.3 | 0.8 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 1.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 2.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 1.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 0.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.3 | 0.5 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 0.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 0.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 3.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 2.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.3 | 1.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 0.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 2.0 | GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus(GO:0039528) |
0.3 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 0.8 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 1.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 0.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 1.8 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.3 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 0.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 3.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 2.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 1.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 1.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 0.5 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.3 | 1.3 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 0.8 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.3 | 1.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 1.8 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.3 | 0.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 1.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 1.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.2 | 0.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.7 | GO:0042148 | strand invasion(GO:0042148) |
0.2 | 0.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 0.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 1.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.5 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.2 | 1.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.7 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 3.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 0.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.5 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 2.2 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 1.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 1.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 2.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 6.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 1.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 0.5 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 1.9 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 1.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.2 | 0.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 1.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 1.9 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.2 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 1.4 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 0.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.7 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 2.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 1.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.5 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 0.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 1.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 1.2 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.2 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.5 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 1.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 1.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.2 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 1.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 0.9 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 1.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.2 | 2.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.7 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.4 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.2 | 0.7 | GO:1903332 | regulation of protein folding(GO:1903332) positive regulation of protein folding(GO:1903334) |
0.2 | 4.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 2.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.2 | 0.9 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 1.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 0.9 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 1.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.8 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 2.2 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 1.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.4 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.2 | 2.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.6 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 1.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.9 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.2 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 1.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 1.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 1.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 2.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.2 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.2 | 0.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 1.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 1.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.8 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 1.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.4 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 1.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 1.0 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 0.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.2 | 0.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 1.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.4 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 2.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 2.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.6 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.2 | 0.2 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.2 | 1.2 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 2.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 1.4 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 0.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.2 | 0.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 3.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 1.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 1.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.4 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.2 | 0.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.2 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.6 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.2 | 1.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.4 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.2 | 1.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 1.4 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 6.8 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.6 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 1.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 1.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 1.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.2 | 0.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 4.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.2 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 0.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.2 | 1.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 1.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 1.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.2 | 1.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 2.1 | GO:0032402 | melanosome transport(GO:0032402) |
0.2 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 1.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 0.2 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.2 | 0.4 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.2 | 1.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 2.0 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.2 | 1.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.2 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.2 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.2 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.2 | 1.3 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 1.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 0.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.7 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.2 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.2 | 0.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 1.6 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 1.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 4.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.7 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.2 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 1.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.7 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 0.2 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.7 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 0.4 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 2.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.2 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 3.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.2 | 0.3 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.2 | 2.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 6.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 1.4 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.2 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.5 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.2 | 0.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.3 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 1.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.3 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.2 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 0.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.5 | GO:0051610 | serotonin uptake(GO:0051610) |
0.2 | 0.5 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.2 | 0.5 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.2 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 3.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.2 | GO:0035482 | gastric motility(GO:0035482) |
0.2 | 0.7 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 0.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.2 | GO:0042368 | vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) |
0.2 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 1.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 3.1 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 1.8 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.5 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.6 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.2 | 4.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 5.1 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.2 | 0.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 4.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 1.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.2 | 2.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 1.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 1.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 1.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.5 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 1.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.2 | 0.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 1.7 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.2 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 2.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.9 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 2.5 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 0.5 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.6 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 1.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.9 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.2 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.2 | 0.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.2 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 1.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 2.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.2 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.6 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 1.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 2.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 3.4 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.1 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 6.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 1.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 1.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.7 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.3 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 1.9 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 1.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 1.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:0071898 | transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.1 | 1.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.3 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 5.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0032371 | regulation of sterol transport(GO:0032371) regulation of cholesterol transport(GO:0032374) |
0.1 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.6 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 1.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.9 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 2.4 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.1 | 1.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.8 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 1.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 2.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.6 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.8 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.3 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 5.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 1.5 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 1.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 2.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.8 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.3 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.1 | 0.5 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 1.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 3.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 3.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.5 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 1.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 2.8 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 3.0 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 1.3 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 6.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.1 | 1.0 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 2.3 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.1 | GO:1903276 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 1.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.8 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 1.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 1.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 3.5 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.6 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 1.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 3.4 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 2.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.6 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.9 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.5 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.9 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.1 | 0.5 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.6 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 4.8 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.1 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.6 | GO:1903902 | positive regulation of viral life cycle(GO:1903902) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.3 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 1.0 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 3.0 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.7 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.1 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.1 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.6 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.4 | GO:0050792 | regulation of viral process(GO:0050792) |
0.1 | 0.7 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.3 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 1.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 3.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.7 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 2.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.1 | 0.2 | GO:0003166 | bundle of His development(GO:0003166) |
0.1 | 0.4 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.4 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 6.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.2 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 1.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 1.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.6 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.2 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 2.5 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 3.7 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
0.1 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.4 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.1 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.6 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.3 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.1 | 0.9 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 1.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 12.6 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.3 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.1 | 0.6 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.5 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 1.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 1.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.5 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 1.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.5 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.1 | 0.1 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.1 | 2.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.8 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 2.0 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 1.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.3 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 1.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.1 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 4.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.2 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.8 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.2 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.1 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 2.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 3.7 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.5 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 1.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.7 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 1.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.6 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 0.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:1902253 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
0.1 | 0.8 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.5 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.1 | GO:0006450 | regulation of translational elongation(GO:0006448) regulation of translational fidelity(GO:0006450) |
0.1 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.1 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.1 | 0.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.1 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.1 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.1 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.5 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 2.3 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 2.2 | GO:0001824 | blastocyst development(GO:0001824) |
0.1 | 0.4 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 1.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.8 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.4 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.1 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.8 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.2 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 1.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.6 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0032094 | response to food(GO:0032094) |
0.1 | 7.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 2.5 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0043328 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.3 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.4 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 2.1 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.3 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.3 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.3 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.2 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 0.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 1.2 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.4 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.3 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.1 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.9 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.2 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.1 | 0.3 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.1 | 0.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.2 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.2 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.4 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.1 | 0.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 2.1 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.1 | 0.6 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.1 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 0.4 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 1.1 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.3 | GO:1901070 | GTP biosynthetic process(GO:0006183) guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 0.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.6 | GO:0043297 | apical junction assembly(GO:0043297) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 1.4 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.0 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.6 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 1.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.3 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 1.1 | GO:0052548 | regulation of endopeptidase activity(GO:0052548) |
0.0 | 0.1 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.0 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.0 | 0.0 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.9 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 0.0 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 0.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.0 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.0 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.2 | GO:0002526 | acute inflammatory response(GO:0002526) |
0.0 | 0.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.3 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.0 | 0.5 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.0 | GO:0009310 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 2.7 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 1.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.0 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.0 | 0.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.0 | 1.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.0 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.3 | GO:0070988 | demethylation(GO:0070988) |
0.0 | 0.1 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.1 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.0 | GO:0036314 | response to sterol(GO:0036314) |
0.0 | 0.4 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) |
0.0 | 0.1 | GO:0035268 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.0 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.0 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.3 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 2.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 1.1 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.2 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 2.1 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.0 | 0.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.0 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.0 | GO:0042503 | tyrosine phosphorylation of STAT protein(GO:0007260) tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.9 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.0 | 0.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.3 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0032400 | melanosome localization(GO:0032400) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.6 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 3.3 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.0 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.3 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.0 | GO:0044264 | cellular polysaccharide metabolic process(GO:0044264) |
0.0 | 0.0 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.0 | 0.0 | GO:0002709 | regulation of T cell mediated immunity(GO:0002709) |
0.0 | 0.0 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.4 | GO:0001890 | placenta development(GO:0001890) |
0.0 | 0.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 0.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.0 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.0 | 0.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.0 | 0.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.1 | GO:0006473 | protein acetylation(GO:0006473) |
0.0 | 0.0 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.0 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 6.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.1 | 3.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.8 | 6.2 | GO:0045179 | apical cortex(GO:0045179) |
0.7 | 0.7 | GO:1903349 | omegasome membrane(GO:1903349) |
0.7 | 2.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.7 | 3.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 3.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 4.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 2.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 2.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.6 | 1.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 3.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 4.9 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 2.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 2.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 2.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 7.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 3.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 2.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.5 | 2.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 3.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 2.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.5 | 1.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 2.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 2.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 1.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 4.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 2.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 3.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 3.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 2.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 1.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 4.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.4 | 1.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 2.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 3.9 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 1.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 1.6 | GO:0000805 | X chromosome(GO:0000805) |
0.4 | 15.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 5.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 1.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 2.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 1.8 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 1.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 0.7 | GO:1990462 | omegasome(GO:1990462) |
0.4 | 1.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 1.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 3.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 1.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 0.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 8.0 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 3.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 1.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 4.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.8 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 1.0 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 2.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 3.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 1.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.7 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 1.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 3.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 1.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 1.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 1.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 1.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 4.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 2.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 2.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 0.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 0.9 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 0.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 2.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 2.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 2.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 2.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 8.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 4.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 3.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.9 | GO:0032797 | SMN complex(GO:0032797) |
0.3 | 2.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 7.1 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 0.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 0.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 1.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 1.3 | GO:0001652 | granular component(GO:0001652) |
0.3 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 3.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 2.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 1.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 4.7 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 29.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 8.4 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 13.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 4.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.7 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 3.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.9 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 3.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 2.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 2.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 12.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 1.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 6.5 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 1.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 1.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 5.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.8 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 1.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.2 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.2 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.6 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 2.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 9.7 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 8.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 4.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 2.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 1.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 0.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.1 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 10.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 1.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 10.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 2.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 6.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 0.5 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 0.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 2.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 2.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.5 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 1.0 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 0.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 0.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.2 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 1.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 5.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 1.6 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 10.3 | GO:0030496 | midbody(GO:0030496) |
0.2 | 1.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 1.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 3.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 50.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 5.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 11.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 9.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 3.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 6.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 6.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 3.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.6 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 4.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 4.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 1.4 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) BAF-type complex(GO:0090544) |
0.1 | 0.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 2.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 15.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 4.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 16.1 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 6.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 2.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.4 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 3.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 3.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 35.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 1.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 8.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 4.4 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.7 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 1.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 2.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 13.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 18.8 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 4.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 3.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 7.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 3.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 2.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 3.3 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 1.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 1.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 1.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.5 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 77.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.8 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 12.4 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.4 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 64.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 1.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.2 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.1 | 1.0 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 2.9 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 70.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 2.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.0 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 1.0 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.0 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 6.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.2 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.1 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 4.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 2.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.0 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 4.4 | GO:0043233 | organelle lumen(GO:0043233) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0031974 | membrane-enclosed lumen(GO:0031974) |
0.0 | 0.0 | GO:0030894 | replisome(GO:0030894) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.0 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0030135 | coated vesicle(GO:0030135) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:1903561 | extracellular organelle(GO:0043230) extracellular vesicle(GO:1903561) |
0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0005657 | replication fork(GO:0005657) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.4 | 9.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.3 | 4.0 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.2 | 3.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.1 | 1.1 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.1 | 3.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.0 | 3.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.0 | 3.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.0 | 3.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.0 | 2.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.9 | 2.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.9 | 2.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.9 | 5.6 | GO:0032052 | bile acid binding(GO:0032052) |
0.9 | 2.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 3.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 3.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.9 | 2.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.9 | 2.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.8 | 2.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 3.2 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 3.1 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.8 | 2.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.7 | 2.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 2.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 5.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 2.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 1.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.7 | 2.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.7 | 2.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.7 | 2.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 2.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.7 | 2.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 2.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 2.0 | GO:0035877 | death effector domain binding(GO:0035877) |
0.7 | 2.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.7 | 3.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.6 | 1.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 3.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.6 | 4.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.6 | 2.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 2.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 1.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.6 | 1.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.6 | 1.7 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 2.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.6 | 1.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 1.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 3.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 2.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 2.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 2.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 1.6 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.5 | 1.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.5 | 1.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 1.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.5 | 4.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 1.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 2.0 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 2.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 1.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 2.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 2.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 1.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 1.5 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 0.5 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 5.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 1.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 0.9 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.5 | 1.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.5 | 3.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.5 | 1.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.5 | 1.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 1.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.5 | 4.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 1.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 3.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.5 | 4.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 4.4 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.4 | 4.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 1.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 1.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 3.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 6.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 2.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 1.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 2.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 1.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 0.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 4.1 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 1.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 2.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 1.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 1.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 2.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 1.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 7.1 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.4 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 1.9 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 4.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 0.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.4 | 1.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 4.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 1.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 8.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 1.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 3.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 1.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 1.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.4 | 1.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 3.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 1.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 1.4 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.3 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 2.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 0.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 0.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 1.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 1.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 1.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 2.7 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.3 | 1.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 2.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 2.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 3.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 1.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 1.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 1.0 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 1.6 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.3 | 5.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 4.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 1.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 2.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 3.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 2.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 1.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.9 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.3 | 2.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 0.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 0.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 0.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 3.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 0.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 0.9 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 33.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 3.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 4.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 1.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 1.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 1.4 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 2.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 8.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 2.2 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 0.6 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 3.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 0.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 0.8 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 1.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 0.8 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 1.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 2.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 1.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.3 | 1.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 0.8 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 1.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.3 | 1.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 2.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 8.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 1.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 4.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 0.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.3 | 2.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 1.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 0.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 1.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 1.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.2 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 3.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 3.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 1.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 1.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 1.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 1.7 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 4.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 1.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.7 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 1.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 1.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 4.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 2.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 2.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 3.7 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 2.7 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 2.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 3.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 3.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 0.7 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.2 | 1.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.9 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 2.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 3.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.2 | 3.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 2.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 2.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 6.4 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.2 | 2.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 5.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.2 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.8 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.8 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 1.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 4.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 5.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.8 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 2.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 2.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 2.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 2.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.8 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 4.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 1.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 2.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 1.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 1.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.2 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.2 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 1.9 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 1.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.2 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 1.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 3.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 4.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 1.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 4.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.4 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 2.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 6.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 3.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 1.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 0.9 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 2.8 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 2.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.9 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 2.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 1.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 16.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 7.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 2.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.7 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 1.3 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 6.0 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 1.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 2.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 1.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.8 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 2.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 1.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 1.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.2 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.6 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.2 | 0.8 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 4.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 1.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 1.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 4.7 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 0.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 1.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 2.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 2.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.6 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 6.9 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 6.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.7 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 2.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 7.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 2.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 2.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 6.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 5.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 3.1 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 3.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 2.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 4.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 6.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.4 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.1 | 2.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 1.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.4 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.1 | 1.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 2.1 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 2.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 9.0 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 2.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 5.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 3.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 2.8 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 2.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 18.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.8 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.6 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 3.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.5 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 2.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 2.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 2.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
0.1 | 2.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 2.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.3 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.4 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 3.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 1.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 1.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.6 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 2.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.9 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 2.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 57.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.5 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0008106 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.3 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 1.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 2.0 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 1.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 7.2 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 1.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 1.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.3 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 9.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.8 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 3.7 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 8.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.0 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.9 | GO:0016829 | lyase activity(GO:0016829) |
0.1 | 3.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.1 | GO:0071617 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 2.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.3 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 0.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 1.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 9.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 5.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 6.1 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 1.0 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 1.1 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 1.0 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 1.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 1.2 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.0 | 1.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.2 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.4 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 9.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 2.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.0 | 0.4 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 1.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 1.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 1.8 | GO:0016791 | phosphatase activity(GO:0016791) |
0.0 | 1.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.8 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 1.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.1 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 1.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.0 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 4.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 5.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 1.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 13.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 3.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 1.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 5.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 3.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 2.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 8.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 8.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 9.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 8.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 1.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 3.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 6.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 15.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 15.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 4.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 11.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 6.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 1.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 6.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 4.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 7.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 1.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 1.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 1.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 10.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 4.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 8.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 3.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 10.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 2.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.1 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 2.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 5.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 4.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 4.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 5.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 8.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 4.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 4.5 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 3.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 12.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 4.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 3.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 2.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 6.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 13.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 10.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 1.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.6 | 6.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 7.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.5 | 1.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 5.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 1.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 4.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.5 | 5.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 3.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 1.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 6.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 3.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 6.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 0.4 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 5.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 0.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 3.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 7.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 8.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 4.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 5.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 3.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 13.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 3.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 2.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 2.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 5.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 1.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 8.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 0.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 8.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 3.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 4.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 3.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 3.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 6.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.3 | 23.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 3.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 1.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 2.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 2.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 3.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 1.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 1.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 4.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 5.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 4.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 5.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 3.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 0.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 3.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 6.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 1.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 2.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 7.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 2.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 5.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 2.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 5.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 1.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 1.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 1.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.2 | 2.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 0.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 2.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 2.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 8.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 3.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 2.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 5.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 4.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 8.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 2.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 3.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 2.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 3.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 0.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 4.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 3.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 4.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 2.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 4.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 1.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 4.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 1.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 9.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 2.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 11.8 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 1.7 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.2 | 1.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 1.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 1.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 1.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 2.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 6.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 4.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 2.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 0.9 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 2.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.0 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 13.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 1.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 3.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.7 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 0.8 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 3.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 6.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 3.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 1.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 11.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 3.5 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.1 | 2.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 6.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 4.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.2 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 3.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 6.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 2.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 3.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 8.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.9 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.4 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 1.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.2 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.5 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.1 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 1.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |